SUMMARY A total of 227 mothers enrolled for periconceptional multivitamin supplementation because of previous neural tube defect (NTD) births took vitamins for less than the recommended minimum period (at least 28 days before conception until two menstrual periods have been missed). Of 213 examined infants/fetuses born to these partially supplemented mothers, two had NTD, one of whom followed four previous NTDs. The observed NTD recurrence rate is similar to that observed in fully supplemented mothers. A further 14 mothers started supplements before the second missed period but after the normal time of neural tube closure. Three of their offspring had NTD. The significance of this apparently high recurrence rate is discussed.
We have previously reported a reduced rate of neural tube defect (NTD) recurrence 'Co-twin included. tlncludes two mothers given Pregnavite Forte F by their GPs.
N/E=unexamined spontaneous abortion.
group 
Discussion
When the periconceptional vitamin supplementation programme for the prevention of NTD was planned, the recommendation that vitamins be taken for at least 28 days before conception was based on an observed association between low maternal red blood cell (RBC) folate and NTD.s Recently this association has been confirmed.6 RBC folate levels cannot be increased very quickly, and 28 days represents a compromise between the time needed to achieve a maximal rise in RBC folate (about three months) and the time parents will postpone a pregnancy which they are keen to start.
The rationale for continuing vitamin supplements until the time of the second missed menstrual period (commonly 42 days after conception) was to ensure that they are taken until well past the time of normal neural tube closure (26 to 27 days).
Despite this advice, 17% of all mothers enrolled in the study did not fulfil these criteria for full supplementation. The reasons for this include: having conceived shortly before or about the time of enrolment; failure of contraceptive measures to protect; periods not having been re-established on a regular basis after a recent termination or after stopping the oral contraceptive pill; an unplanned pregnancy in a mother who had previously had a planned supplemented one; forgetting to take the vitamins for >1 day.
It is interesting to note that the NTD recurrence rate in these partially supplemented mothers (two of 213, 0.94%) is similar to that seen in fully supplemented mothers. At the time of our last publication2 the rate in FS mothers was 07% (three of 429). In the period during which the 213 PS mothers have been studied, 1107 mothers have been fully supplemented, of whom 14 have had NTD recurrences (1.26%, table 3). Thus it may be that the full supplementation regimen we originally proposed is not, in fact, strictly necessary: rather, a shorter period of therapy may suffice. This is of immense practical importance for the prevention of NTD, because the shorter the period of supplementation advised, the more people are likely to comply. As yet, our numbers of PS women are small, and more are required, for it is only from such women that the minimum effective duration of supplementation can be derived.
Our findings in mothers who started vitamin supplements after the estimated date of neural tube closure, and who are therefore effectively unsupplemented, are unexpected and of particular interest although, being few in number, their experiences must be interpreted with great caution.
Three NTD recurrences were seen among 13 infants/fetuses, supplements having been started on estimated days 31, 34, and 35 after conception ( 
